SCHEMBL20812420

SCHEMBL20812420

O=C1CCC(Nc2n[nH]c3ccccc23)C(=O)N1

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 20/20 0.59
CRBN Q96SW2 20/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19586797 0.83 CRBN (0.59) DDB1CRBN
SCHEMBL19586378 0.83 CRBN (0.59) DDB1CRBN
SCHEMBL19586490 0.79 CRBN (0.44) DDB1CRBN
SCHEMBL20812609 0.78 MAPK10 (0.40)
SCHEMBL19370714 0.78 NPC1 (0.60) DDB1CRBN
SCHEMBL19359344 0.78 NPC1 (0.60) DDB1CRBN
SCHEMBL30899435 0.78 NPC1 (0.60) DDB1CRBN
SCHEMBL21965481 0.75 DDB1 (1.00) DDB1CRBN
SCHEMBL21965879 0.74 DDB1 (0.56) DDB1CRBN
SCHEMBL20805224 0.74 DDB1 (0.58) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190076539-A1 AMINE-LINKED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION C4 Theraprutics, Inc. (US) 2019-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190076539-A1 AMINE-LINKED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION GCGR, STUB1, GID4 DDB1 503/4885CRBN 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.